May 10 (Reuters)-
Haba Laboratories Inc
CONSOLIDATED FINANCIAL HIGHLIGHTS
(in billions of yen unless specified)
Year ended Year ended Year to NEXT
Mar 31, 2024 Mar 31, 2023 Mar 31, 2025 YEAR
LATEST YEAR-AGO COMPANY COMPANY
RESULTS RESULTS FORECAST H1 FORECAST
Sales 12.32 12.04 12.65
(+2.4 pct) (-6.7 pct) (+2.6 pct)
Operating loss 187 mln loss 609 mln 410 mln
Recurring loss 191 mln loss 582 mln 400 mln
Net
Net loss 2.12 loss 707 mln 400 mln
EPS loss 560.26 yen loss 187.19 yen 105.77 yen
Ann Div 40.00 yen 40.00 yen 40.00 yen
-Q2 Div NIL NIL NIL
-Q4 Div 40.00 yen 40.00 yen 40.00 yen
NOTE - Haba Laboratories Inc.
*Second Net profit row denotes profit attributable to owners ofthe parent
To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4925.T